Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Jochen, Metzger"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/30d4f425e37641049b46fe8dd3797d64
Autor:
Alexis Piedrafita, Justyna Siwy, Julie Klein, Amal Akkari, Ana Amaya-garrido, Alexandre Mebazaa, Anna Belen Sanz, Benjamin Breuil, Laura Montero Herrero, Bertrand Marcheix, François Depret, Lucie Fernandez, Elsa Tardif, Vincent Minville, Melinda Alves, Jochen Metzger, Kidney Attack Study Group, Julia Grossac, Harald Mischak, Alberto Ortiz, Stéphane Gazut, Joost P. Schanstra, Stanislas Faguer, Nicolas Mayeur, Audrey Casemayou, François Labaste
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-15 (2022)
Abstract Background The delayed diagnosis of acute kidney injury (AKI) episodes and the lack of specificity of current single AKI biomarkers hamper its management. Urinary peptidome analysis may help to identify early molecular changes in AKI and gra
Externí odkaz:
https://doaj.org/article/dc9afc6aa5d74526857ba1f9594bcd9a
Autor:
Wilfried Gwinner, MD, Annika Karch, PhD, Jan H. Braesen, MD, Abedalrazag A. Khalifa, MD, Jochen Metzger, PhD, Maarten Naesens, MD, Elisabet Van Loon, MD, Dany Anglicheau, MD, Pierre Marquet, PhD, Klemens Budde, MD, Mareen Matz, PhD, Wolfgang Arns, MD, Michael Fischereder, MD, Antje Habicht, MD, Ute Eisenberger, MD, Anja Mühlfeld, MD, Martin Busch, MD, Michael Wiesener, MD, Irina Scheffner, PhD,, Armin Koch, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 5, p e1316 (2022)
Background. Timely recognition and treatment of acute kidney graft rejection is important to prevent premature graft failure. A predefined urinary marker set for acute T cell–mediated rejection (TCMR) containing 14 peptides was tested for this purp
Externí odkaz:
https://doaj.org/article/b3e9ed446cae4b729c75c1e914a62033
Autor:
Alexis Piedrafita, Justyna Siwy, Julie Klein, Amal Akkari, Ana Amaya-garrido, Alexandre Mebazaa, Anna Belen Sanz, Benjamin Breuil, Laura Montero Herrero, Bertrand Marcheix, François Depret, Lucie Fernandez, Elsa Tardif, Vincent Minville, Melinda Alves, Jochen Metzger, Kidney Attack Study Group, Julia Grossac, Harald Mischak, Alberto Ortiz, Stéphane Gazut, Joost P. Schanstra, Stanislas Faguer
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/249024bcc70447dc90394d36633b698c
Autor:
Torsten Voigtländer, Jochen Metzger, Holger Husi, Martha M. Kirstein, Martin Pejchinovski, Agnieszka Latosinska, Maria Frantzi, William Mullen, Thorsten Book, Harald Mischak, Michael P. Manns
Publikováno v:
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-14 (2020)
Abstract Background Detection of cholangiocarcinoma (CCA) remains a diagnostic challenge. We established diagnostic peptide biomarkers in bile and urine based on capillary electrophoresis coupled to mass spectrometry (CE-MS) to detect both local and
Externí odkaz:
https://doaj.org/article/b437f37bb05142849b693743fd5a71d4
Autor:
Ayman S. Bannaga, Jochen Metzger, Ioannis Kyrou, Torsten Voigtländer, Thorsten Book, Jesus Melgarejo, Agnieszka Latosinska, Martin Pejchinovski, Jan A. Staessen, Harald Mischak, Michael P. Manns, Ramesh P. Arasaradnam
Publikováno v:
EBioMedicine, Vol 62, Iss , Pp 103083- (2020)
Background: Liver fibrosis is a consequence of chronic inflammation and is associated with protein changes within the hepatocytes structure. In this study, we aimed to investigate if this is reflected by the urinary proteome and can be explored to di
Externí odkaz:
https://doaj.org/article/eb520815cbc84ccdad6e68dfd109e716
Autor:
Jan A Staessen, Ralph Wendt, Yu-Ling Yu, Sven Kalbitz, Lutgarde Thijs, Justyna Siwy, Julia Raad, Jochen Metzger, Barbara Neuhaus, Armin Papkalla, Heiko von der Leyen, Alexandre Mebazaa, Emmanuel Dudoignon, Goce Spasovski, Mimoza Milenkova, Aleksandra Canevska-Taneska, Mercedes Salgueira Lazo, Mina Psichogiou, Marek W Rajzer, Łukasz Fuławka, Magdalena Dzitkowska-Zabielska, Guenter Weiss, Torsten Feldt, Miriam Stegemann, Johan Normark, Alexander Zoufaly, Stefan Schmiedel, Michael Seilmaier, Benedikt Rumpf, Mirosław Banasik, Magdalena Krajewska, Lorenzo Catanese, Harald D Rupprecht, Beata Czerwieńska, Björn Peters, Åsa Nilsson, Katja Rothfuss, Christoph Lübbert, Harald Mischak, Joachim Beige, Lukasz Fulawka, Harald Rupprecht, Beata Czerwienska, Jörg Ermisch, Nils Kellner, Lydia Peruth-Stutzmann, Stefanie Schroth, Jonathan Schmidt, Ulrike Schmidt, Daniel Breuer, Fariza Abeud, Marie-Celine Fournier, Badr Louadah, Rocio Molas, Fraile Loreto Rojas, Fabiola Alonso García, Isabel Garcia Sánchez, Ioana Cezara Hrom, Andrzej Więczek., Matthias Schwab, Kei K Asayama, Tine W Hansen, Gladys E Maestre, Dimitrios Basoulis, Georgios Karamanakos., Pawel Lis, Agnieszka Olszanecka, Rosa Bellmann-Weiler, Lucas Lanser, Alicia Edin, Matthias NE Forsell, Bernd Stegmayr, Björn-Erik Ole Jensen, Hans-Martin Orth, Sylke Borstel, Agata Mikolajewska, Manfred Hecking, Lukas Schmölz, Michał Hoffmann, Krzysztof Narkiewicz, Agnieszka Matera-Witkiewicz, Justyna Zachciał, Monika Litwin, Patrycja Marciniak
BACKGROUND: The SARS-CoV-2 pandemic is a worldwide challenge. The CRIT-CoV-U pilot study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which predicted death and disease progression from SARS-CoV-2. After the interim analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3973ebe41317826f1bb3b476708a01e7
https://lirias.kuleuven.be/handle/20.500.12942/704971
https://lirias.kuleuven.be/handle/20.500.12942/704971
Autor:
Friedrich Stolzl, S. von Harsdorf, Irina Türüchanow, Karin Westphal, Arnold Ganser, Donald Bunjes, Michael Stadler, Gernot Beutel, Armin Papkalla, Danny Jonigk, Steve Ehrlich, Diethelm Messinger, Lothar Hambach, Johannes Schetelig, Heiko von der Leyen, Hans Kreipe, Stefan Klein, Wolfgang Bethge, Iyas Hamwi, Eva M. Weissinger, Eva-Maria Wagner-Drouet, Julia Raad, Jürgen Krauter, Michael Schleuning, Ernst Holler, Herrad Baurmann, Andreas Rank, Jochen Metzger, Christoph Schmid, Daniela Heidenreich, Kerstin Schäfer-Eckart
Publikováno v:
Leukemia
Acute graft-versus-host disease (aGvHD) contributes to about 50% of transplant-related mortality (non-relapse mortality) after allogeneic hematopoietic stem cell transplantation (HSCT). Here the predictive value of a urinary proteomic profile (aGvHD_
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ef8d094b1295c65c5f7e4f568b6faad
https://doi.org/10.1038/s41375-020-01059-3
https://doi.org/10.1038/s41375-020-01059-3
Publikováno v:
Expert Review of Proteomics. 17:201-206
Introduction: After the genomic era, the analysis of the proteome has gained increasing importance. Peptides and/or proteins present in tissue or body fluids can depict health and are prone to change during disease, not only in configuration but also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cad6a5704051b10a2f8a4fecce08acc5
https://doi.org/10.1080/14789450.2020.1748501
https://doi.org/10.1080/14789450.2020.1748501
Autor:
David Marx, Dany Anglicheau, Sophie Caillard, Bruno Moulin, Audrey Kochman, Harald Mischak, Martin Pejchinowski, Agnieszka Latosinska, Frank Bienaimé, Dominique Prié, Pierre Marquet, Peggy Perrin, Wilfried Gwinner, Jochen Metzger
Kidney transplant recipients (KTR) are at increased risk of fractures. Total urinary hydroxyproline excretion used to be a marker for bone resorption (BR) but faded into the background when more specific markers like Beta-CrossLaps (CTX) became avail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3732f0b909d4fa15271d1cdc09d16325
https://doi.org/10.1101/2022.02.15.22270979
https://doi.org/10.1101/2022.02.15.22270979